NKGen Biotech is a company in the clinical biotechnology sector with a focus on advancing and bringing to market groundbreaking autologous, allogeneic and CAR-NK natural killer cell therapies through our exclusive SNK (super-activated) platform. Leading the way in revolutionizing our industry, we have a group of experienced Senior Leadership, Senior Advisors, and Management Team. Together, they possess a wealth of expertise and knowledge in the immune-oncology field and are enthusiastic and dedicated to our efforts in fortifying the immune system.